Choosing the NovaSure procedure
As you likely already know, many women suffering from heavy menstrual bleeding don't speak up. They're either embarrassed about their heavy bleeding, they don't know that AUB is a serious medical condition, or they don't realize there are viable treatment options. But AUB can have a devastating impact. Consider this:
These are just a few of the symptoms of AUB that affect patients' lives. When discussing the NovaSure procedure and GEA, you can reassure them that:
Who may be candidates?
Women who suffer most from the following symptoms of heavy menstrual bleeding may be candidates for the NovaSure procedure:
The procedure is contraindicated for use in:
- A patient who is pregnant or who wants to become pregnant in the future. Pregnancies following ablation can be dangerous for both mother and fetus
- A patient with known or suspected endometrial carcinoma (uterine cancer) or pre-malignant conditions of the endometrium, such as unresolved adenomatous hyperplasia
- A patient with any anatomic condition (e.g., history of previous classical cesarean section or transmural myomectomy) or pathologic condition (e.g., long-term medical therapy) that could lead to weakening of the myometrium
- A patient with active genital or urinary tract infection at the time of the procedure (e.g., cervicitis, vaginitis, endometritis, salpingitis, or cystitis)
- A patient with a intrauterine device (IUD) currently in place
- A patient with a uterine cavity length less than 4 cm. The minimum length of the electrode array is 4 cm. Treatment of a uterine cavity with a length less than 4 cm will result in thermal injury to the endocervical canal.
- A patient with a uterine cavity width less than 2.5 cm, as determined by the WIDTH dial of the disposable device following device deployment
- A patient with active pelvic inflammatory disease
You may also want to review a full list of the risks and benfits with your patient.
Give your patients "The Heavy Period Quiz"
It's not always easy to identify those patients who may be appropriate candidates for endometrial ablation and the NovaSure procedure. Often women consider their heavy bleeding as normal, instead of a serious medical condition. Some are embarrassed to talk about the discomfort and disruption it causes in their lives.
Get the conversation started
You could also begin a conversation with patients who you feel may be uncomfortable talking about their symptoms by asking a few of these simple questions:
You may also want to review these questions with your staff to help them identify those patients affected by heavy menstrual bleeding.
Educate your patients about the NovaSure procedure
In addition to extensive after-sales support, along with a highly visible direct-to-patient marketing program, Hologic has developed extensive patient education materials. You can include these in your waiting area or have staff provide them to patients as they are waiting for their appointments. You can also take advantage of our professionally created materials to help generate awareness of your endometrial ablation capabilities.
Simply visit our online Patient Outreach Toolkit and register to order—or download—ready-to-print materials to support your patient education and marketing program. These include:
1. National Women’s Health Resource Center. Survey of women who experience heavy menstrual bleeding. Data on file; 2005. 2. Cooper J, et al. A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia. J Am Assoc Gynecol Laparosc. 2002; 9:418-428. 3. Gimpelson R, Ten-year literature review of global endometrial ablation with the NovaSure device, Int J of Women’s Health, 2014 4. NovaSure Instructions for Use. 5. Endometrial Ablation. ACOG Practice Bulletin No. 81. American College of Obstetrics and Gynecology, Obstet Gynecol 2007; 109: 1233-1248.